News

BioGaia has signed a distribution agreement with the French company, Laboratoires Bioethic. The agreement gives Laboratoires Bioethic exclusive rights to sell BioGaia´s Probiotic drops and tablets in France.

Cambridge Regulatory Services (CambReg) has formed a strategic alliance with SIRO Clinpharm, a clinical research organisation. The new alliance will provide benefits to pharma companies in both Asia

Jennerex has disclosed the second and final closing of a private placement financing with aggregate gross proceeds of $5.6m exceeding the target of $5m. As previously reported by

Wyeth Pharmaceuticals has announced the formation of a worldwide alliance to discover, develop, and commercializes protein drug candidates for three undisclosed targets in multiple therapeutic areas. The alliance

Sanofi-Aventis and Merck have reported that the acquisition by Sanofi-Aventis of Merck’s 50% interest in Merial has been completed. Sanofi-aventis acquired Merck’s interest in Merial for a cash

Arena Pharmaceuticals has disclosed results from the Behavioral modification and Lorcaserin second study for obesity management trial (BLOSSOM). BLOSSOM confirms the results previously reported for the Behavioral modification

Millennium has announced that the FDA has granted priority review to the company’s supplemental new drug application (sNDA) for VELCADE. The sNDA contains long-term overall survival (OS) data

California Stem Cell (CSC) and Stemina Biomarker Discovery have announced that the study using CSC’s 96-well CardioPlate containing high purity human embryonic stem cell (hESC)-derived cardiomyocyte progenitor cells,

Teijin, a fine chemical company, has announced that it has begun producing its proprietary heat-resistant bioplastic BIOFRONT at a demonstration plant in Matsuyama, Ehime Prefecture. The plant was